However, with respect to sNK-based cytokine secretion of IFN-γ, there is a potential pathway to now upregulate MHC-I in the poorly-differentiated HCC, leading to MHC-based antigen presentation and recognition and subsequent T cell activation (35, 36). The gene discussed is HLA-C; the disease is hepatocellular carcinoma.